IMC Chicago’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$783K Buy
85,300
+48,300
+131% +$539K ﹤0.01% 4138
2026
Q1
$401K Sell
37,000
-31,300
-46% -$268K ﹤0.01% 4270
2025
Q4
$417K Sell
68,300
-29,300
-30% -$175K ﹤0.01% 3593
2025
Q3
$506K Buy
97,600
+10,500
+12% +$60.4K ﹤0.01% 3169
2025
Q2
$517K Buy
87,100
+31,900
+58% +$192K ﹤0.01% 2844
2025
Q1
$454K Buy
55,200
+30,700
+125% +$258K ﹤0.01% 2726
2024
Q4
$202K Buy
+24,500
New +$197K ﹤0.01% 3101
2024
Q3
Sell
-40,300
Closed -$418K 2980
2024
Q2
$418K Buy
+40,300
New +$442K ﹤0.01% 2363

Other funds holding PTEN

IMC Chicago's PTEN Position: Q2 2026 in Review

IMC Chicago opened a new position in Patterson-UTI (PTEN) in Q2 2026: 18,657 shares worth $171K. The stake represents ﹤0.01% of the portfolio and ranks #5762 among its holdings. This is a return to the name: IMC Chicago previously reported a position in PTEN as recently as Q3 2025.

IMC Chicago first reported a position in PTEN in Q1 2025 and has held it in 4 quarters since. The position peaked at $385K in Q3 2025. 438 funds tracked by Wall St. Rank hold PTEN as of Q2 2026.

  • IMC Chicago held 18,657 shares of Patterson-UTI worth $171K as of Q2 2026.
  • Patterson-UTI was a new IMC Chicago position in Q2 2026.
  • Patterson-UTI made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #5762 holding.
  • IMC Chicago first reported a position in Patterson-UTI in Q1 2025 and has held it in 4 quarters since.
  • IMC Chicago's Patterson-UTI position peaked at $385K in Q3 2025.
  • 438 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.